IDRx

Series-B+ Acquired by GlaxoSmithKline
idrx.com Biotech & Healthcare Cambridge, United States Founded 2022 11-50
Total Funding $242M
Latest Round $120M Series-B+
Last Announced Aug 8, 2024
Investors 10 Backers
Decision Makers 6 Verified

About IDRx

IDRx is a clinical-stage biopharmaceutical company that develops oncology-based precision therapies. It designs precision combination therapies, which are medicines with engineered drug combinations. These therapies aim to stop key tumor escape mechanisms and prolong response to therapy for gastrointestinal stromal tumors.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2022
Team Size 11-50
Corporate Status Acquired by GlaxoSmithKline
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website idrx.com
Domain Registered Date Jul 30, 2005

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $120,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $122,000,000 · Series-A

    fundraisingfox.com

  3. Milestone

    Company founded

    Cambridge, United States

  4. Milestone

    Website domain registered

    idrx.com

Investors & Backers

10
Andreessen Horowitz
Blackstone
Casdin Capital
Commodore Capital
Forge Life Science Partners
Merck KGaA, Darmstadt, Germany
Nextech Invest
Nick Lydon
RA Capital Management
Rock Springs Capital

Funding History

2 Rounds
Series-B+ · Aug 8, 2024
Series-A · Aug 2, 2022

Founders & Leadership

9

Alexis Borisy

Founder

Work email & phone locked Unlock →

Ben Auspitz

Founder

Work email & phone locked Unlock →

George Demetri

Founder

Work email & phone locked Unlock →

Jessica Anderson

Chief Development Operations Officer

Work email & phone locked Unlock →

Jessica Christo

Chief Development Operations Officer

Work email & phone locked Unlock →

Nick Lydon

Founder

Work email & phone locked Unlock →

Robert Forrester

Founder

Work email & phone locked Unlock →

Shrenik Desai

Vice President, Regulatory Affairs

Work email & phone locked Unlock →

Vic Kadambi

Chief Product Development Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts